Novel (3.2.0.) bicycloheptanone oxime ethers with valuable therapeutic properties
申请人:SYNTEX (U.S.A.) INC.
公开号:EP0100900A1
公开(公告)日:1984-02-22
Compounds useful in treating cardiovascular disorders are the carboxylic acids depicted in formulas (1) and (2)
as well as their pharmaceutically acceptable, non-toxic salts and esters, wherein:
n is an integer from one to four;
R1 is hydroxy;
R2 is hydrogen; or
R1 and Rz together are an oxo group;
R3 is
wherein
A is -CH2-CH2-; trans-CH=CH-; -C≡C-; and
R4 is linear or branched alkyl of one to twelve carbons, cycloalkyl of three to eight carbons; phenyl optionally substituted with one or two identical substituents selected from the group consisting of lower alkyl, lower alkoxy, hydroxy, trifluoromethyl, and halo; or optionally substituted phenylalkyl.
用于治疗心血管疾病的化合物是式(1)和(2)所示的羧酸类化合物
及其药学上可接受的无毒盐类和酯类,其中
n 是一至四的整数;
R1 是羟基
R2 是氢;或
R1 和 Rz 合在一起是一个氧代基团;
R3 是
其中
A 是-CH2-CH2-;反式-CH=CH-;-C≡C-;和
R4 是 1 至 12 个碳原子的直链或支链烷基、3 至 8 个碳原子的环烷基、任选被选自低 级烷基、低级烷氧基、羟基、三氟甲基和卤基的一个或两个相同取代基取代的苯基、 或任选被取代的苯基烷基。